Gossamer Bio Inc (GOSS) is a biopharmaceutical company that focuses on discovering, developing, and commercializing immunology-based therapies to help patients with serious unmet medical needs. The company's pipeline includes potential treatments for various indications, such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD), and other immune-related disorders. GOSS was founded in 2015 and is headquartered in San Diego, California.
Gossamer Bio Inc (GOSS) is a biopharmaceutical company that focuses on discovering, developing, and commercializing immunology-based therapies to help patients with serious unmet medical needs. The company's pipeline includes potential treatments for various indications, such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD), and other immune-related disorders. GOSS was founded in 2015 and is headquartered in San Diego, California.